
    
      The primary objective of the study is to determine the effect of testosterone replacement on
      time to disease progression and time to clinical cancer progression.

      The secondary objectives are to describe the effect of testosterone replacement on
      patient-reported quality of life (FACT-P, FACT-fatigue and specific measures from the
      Expanded Prostate Cancer Index (EPIC): Sexual and Hormonal Assessments), and hand-grip
      strength; to describe changes in total testosterone, free testosterone, and PSA levels; to
      explore AR levels in circulating tumor cells as a marker of treatment benefit.
    
  